Guides / Clinical Topics
Clinical Topic Guide

Medication Errors Nursing Capstone

Medication errors remain a leading cause of preventable patient harm. This guide shows you how to build a focused, evidence-grounded capstone project — from a strong PICOT to an implementation plan faculty will respect.

Medication errors are the second most common cause of preventable harm in U.S. hospitals, responsible for approximately 1.5 million preventable adverse drug events per year according to IOM estimates. For a capstone, this means the clinical significance section practically writes itself — the harder work is narrowing the topic. Medication safety spans prescribing errors, transcription errors, dispensing errors, administration errors, and monitoring failures. A strong capstone picks one phase of the medication use process and one population, then proposes a targeted intervention with measurable outcomes.

Types of medication errors: choose your focus

Before writing your PICOT, decide which phase of the medication use process your project addresses. Each phase has different interventions and different evidence:

PhaseCommon error typesCommon interventions
PrescribingWrong drug, wrong dose, drug-drug interactions, allergy not checkedClinical decision support, pharmacist review, standardized order sets
Transcription / order entryMisread orders, CPOE entry errors, abbreviation useCPOE systems, prohibited abbreviation lists, read-back protocols
DispensingWrong medication dispensed, look-alike/sound-alike (LASA) errorsBarcode medication dispensing, LASA alert flags, unit-dose packaging
AdministrationWrong route, wrong time, wrong patient, wrong doseBarcode medication administration (BCMA), five rights checklists, nurse education
MonitoringFailure to detect adverse reactions, missed lab valuesStructured medication reconciliation, pharmacist-nurse collaboration protocols

PICOT question examples

Three levels of PICOT specificity

Too broad: In hospitalized patients, does medication safety training reduce medication errors compared to no training within 6 months?

Acceptable: In adult medical-surgical nurses, does barcode medication administration (BCMA) reduce medication administration errors compared to manual five-rights checks over 3 months?

Strong: In adult ICU patients receiving high-alert medications (insulin, heparin, vasopressors), does a nurse-led double-check protocol combined with pharmacist co-verification reduce administration errors compared to single-nurse verification over a 90-day period?

Key evidence sources for medication safety

Get help with your medication safety capstone

Share your focus area (administration, reconciliation, high-alert meds) and your PICOT draft. A polished, evidence-based capstone project comes back built to your rubric.

Start your project Compare: fall prevention

Implementation frameworks for medication safety

The PDSA cycle (Plan-Do-Study-Act) is the most commonly used framework for medication safety QI projects because it aligns with how hospitals actually test safety interventions. The Iowa Model works equally well for EBP-framed capstones. At MSN level, Kurt Lewin's Change Theory or Kotter's 8-Step Change Model can frame the organizational change aspect of implementing a new medication safety protocol.

Outcome measures to use

Related guides

Medication errors capstone FAQ

Can I focus on a specific drug class (e.g., insulin, anticoagulants) for my capstone?

Yes — and you should. High-alert medications (insulin, anticoagulants, opioids, chemotherapy) are the most impactful focus for a medication safety capstone because the consequences of errors are severe and the evidence base for specific interventions is strong. ISMP publishes a list of high-alert medications with specific recommendations — use it to ground your intervention choice in authoritative guidance.

Does a medication safety capstone require access to error data from my clinical site?

For a proposal-style capstone (most BSN programs), you do not need actual error data from your site. You establish clinical significance using published national data (ISMP, AHRQ, The Joint Commission) and describe the types of errors your proposed intervention would address. If your program requires a pilot or QI component, work with your clinical site to access de-identified aggregate data — individual patient data requires IRB consideration.